id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-0051-0002,FDA,FDA-1998-N-0051,Over-The-Counter Human Drugs; Labeling Requirements;,Rule,Correction,1999-04-19T04:00:00Z,1999,4,,,2016-08-08T18:54:06Z,64FR18571,0,0,090000648056e85a
FDA-1998-N-0051-0001,FDA,FDA-1998-N-0051,Over-The-Counter Human Drugs; Labeling Requirements,Rule,Final Rule,1999-03-18T05:00:00Z,1999,3,1999-03-11T05:00:00Z,1999-04-17T03:59:59Z,2016-08-27T19:05:01Z,,0,0,090000648056e83f